DrugPatentWatch Database Preview
Details for Patent: 9,095,615
Try a free trial
See Plans and Pricing
Which drugs does patent 9,095,615 protect, and when does it expire?
Patent 9,095,615 protects HYSINGLA and is included in one NDA.
This patent has two hundred and ten patent family members in forty countries.
Summary for Patent: 9,095,615
| Title: | Tamper resistant dosage forms |
| Abstract: | The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof. |
| Inventor(s): | McKenna; William H. (Yonkers, NY), Mannion; Richard O. (Furlong, PA), O'Donnell; Edward P. (Basking Ridge, NJ), Huang; Haiyong H. (Princeton, NJ) |
| Assignee: | PURDUE PHARMA L.P. (Stamford, CT) PURDUE PHARMACEUTICALS L.P. (Wilson, NC) |
| Application Number: | 14/515,921 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,095,615 |
|
Patent Claim Types: see list of patent claims | Composition; Dosage form; Process; Device; |
Drugs Protected by US Patent 9,095,615
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Purdue Pharma Lp | HYSINGLA | hydrocodone bitartrate | TABLET, EXTENDED RELEASE;ORAL | 206627-001 | Nov 20, 2014 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | ||||
| Purdue Pharma Lp | HYSINGLA | hydrocodone bitartrate | TABLET, EXTENDED RELEASE;ORAL | 206627-002 | Nov 20, 2014 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | ||||
| Purdue Pharma Lp | HYSINGLA | hydrocodone bitartrate | TABLET, EXTENDED RELEASE;ORAL | 206627-003 | Nov 20, 2014 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | ||||
| Purdue Pharma Lp | HYSINGLA | hydrocodone bitartrate | TABLET, EXTENDED RELEASE;ORAL | 206627-004 | Nov 20, 2014 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | ||||
| Purdue Pharma Lp | HYSINGLA | hydrocodone bitartrate | TABLET, EXTENDED RELEASE;ORAL | 206627-005 | Nov 20, 2014 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,095,615
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| African Regional IP Organization (ARIPO) | 2355 | ➤ Sign Up | |||
| Argentina | 062511 | ➤ Sign Up | |||
| Argentina | 103463 | ➤ Sign Up | |||
| Argentina | 109796 | ➤ Sign Up | |||
| Argentina | 109797 | ➤ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
